$315,97
-$6,49(-2,01%)
*Data last updated: 2026-04-10 14:38 (UTC+8)
As of 2026-04-10 14:38, Cencora Inc. (COR) is priced at $315,97, with a total market cap of $62,72B, a P/E ratio of 38,97, and a dividend yield of 0,71%. Today, the stock price fluctuated between $314,61 and $321,16. The current price is 0,43% above the day's low and 1,61% below the day's high, with a trading volume of 1,19M. Over the past 52 weeks, COR has traded between $308,54 to $325,84, and the current price is -3,02% away from the 52-week high.
COR Key Stats
Yesterday's Close$324,93
Market Cap$62,72B
Volume1,19M
P/E Ratio38,97
Dividend Yield (TTM)0,71%
Dividend Amount$0,60
Diluted EPS (TTM)8,36
Net Income (FY)$1,55B
Revenue (FY)$321,33B
Earnings Date2026-05-06
EPS Estimate4,83
Revenue Estimate$81,12B
Shares Outstanding193,05M
Beta (1Y)0.718
Ex-Dividend Date2026-02-13
Dividend Payment Date2026-03-02
About COR
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
SectorHealthcare
IndustryMedical - Distribution
CEORobert Mauch
HeadquartersConshohocken,PA,US
Official Websitehttps://www.cencora.com
Employees (FY)51,00K
Average Revenue (1Y)$6,30M
Net Income per Employee$30,47K
Cencora Inc. (COR) FAQ
What's the stock price of Cencora Inc. (COR) today?
x
Cencora Inc. (COR) is currently trading at $315,97, with a 24h change of -2,01%. The 52-week trading range is $308,54–$325,84.
What are the 52-week high and low prices for Cencora Inc. (COR)?
x
What is the price-to-earnings (P/E) ratio of Cencora Inc. (COR)? What does it indicate?
x
What is the market cap of Cencora Inc. (COR)?
x
What is the most recent quarterly earnings per share (EPS) for Cencora Inc. (COR)?
x
Should you buy or sell Cencora Inc. (COR) now?
x
What factors can affect the stock price of Cencora Inc. (COR)?
x
How to buy Cencora Inc. (COR) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.
